448 related articles for article (PubMed ID: 26386610)
1. Comparative effectiveness and safety of indomethacin versus ibuprofen for the treatment of patent ductus arteriosus.
Gulack BC; Laughon MM; Clark RH; Sankar MN; Hornik CP; Smith PB
Early Hum Dev; 2015 Dec; 91(12):725-9. PubMed ID: 26386610
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of pharmacologic closure of patent ductus arteriosus in small-for-gestational-age extremely preterm infants.
Boghossian NS; Do BT; Bell EF; Dagle JM; Brumbaugh JE; Stoll BJ; Vohr BR; Das A; Shankaran S; Sanchez PJ; Wyckoff MH; Bethany Ball M;
Early Hum Dev; 2017 Oct; 113():10-17. PubMed ID: 28697406
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness and safety of indomethacin versus ibuprofen for the treatment of patent ductus arteriosus in preterm infants.
Sivanandan S; Bali V; Soraisham AS; Harabor A; Kamaluddeen M
Am J Perinatol; 2013 Oct; 30(9):745-50. PubMed ID: 23322388
[TBL] [Abstract][Full Text] [Related]
4. Variation and comparative effectiveness of patent ductus arteriosus pharmacotherapy in extremely low birth weight infants.
ElHassan NO; Bird TM; King AJ; Ambadwar PB; Jaquiss RD; Kaiser JR; Robbins JM
J Neonatal Perinatal Med; 2014 Jan; 7(3):229-35. PubMed ID: 25322995
[TBL] [Abstract][Full Text] [Related]
5. Comparative study of the efficacy and safety of paracetamol, ibuprofen, and indomethacin in closure of patent ductus arteriosus in preterm neonates.
El-Mashad AE; El-Mahdy H; El Amrousy D; Elgendy M
Eur J Pediatr; 2017 Feb; 176(2):233-240. PubMed ID: 28004188
[TBL] [Abstract][Full Text] [Related]
6. Ibuprofen versus indomethacin treatment of patent ductus arteriosus: comparative effectiveness and complications.
Chan NM; Law CW; Kwan KF
Hong Kong Med J; 2014 Jun; 20(3):205-12. PubMed ID: 24493687
[TBL] [Abstract][Full Text] [Related]
7. Timing of pharmacological treatment for patent ductus arteriosus and risk of secondary surgery, death or bronchopulmonary dysplasia: a population-based cohort study of extremely preterm infants.
Gudmundsdottir A; Johansson S; Håkansson S; Norman M; Källen K; Bonamy AK
Neonatology; 2015; 107(2):87-92. PubMed ID: 25412681
[TBL] [Abstract][Full Text] [Related]
8. Oral ibuprofen and indomethacin for treatment of patent ductus arteriosus in premature infants: a randomized trial at Ramathibodi Hospital.
Supapannachart S; Limrungsikul A; Khowsathit P
J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1252-8. PubMed ID: 12549803
[TBL] [Abstract][Full Text] [Related]
9. Changes in the Diagnosis and Management of Patent Ductus Arteriosus from 2006 to 2015 in United States Neonatal Intensive Care Units.
Bixler GM; Powers GC; Clark RH; Walker MW; Tolia VN
J Pediatr; 2017 Oct; 189():105-112. PubMed ID: 28600155
[TBL] [Abstract][Full Text] [Related]
10. A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus.
Van Overmeire B; Smets K; Lecoutere D; Van de Broek H; Weyler J; Degroote K; Langhendries JP
N Engl J Med; 2000 Sep; 343(10):674-81. PubMed ID: 10974130
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic closure of the ductus arteriosus: benefits and limitations.
Mercanti I; Boubred F; Simeoni U
J Matern Fetal Neonatal Med; 2009; 22 Suppl 3():14-20. PubMed ID: 19925358
[TBL] [Abstract][Full Text] [Related]
12. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants.
Ohlsson A; Walia R; Shah SS
Cochrane Database Syst Rev; 2010 Apr; (4):CD003481. PubMed ID: 20393936
[TBL] [Abstract][Full Text] [Related]
13. Treatment of patent ductus arteriosus: indomethacin or ibuprofen?
Linder N; Bello R; Hernandez A; Rosen C; Birk E; Sirota L; Pushkov Y; Klinger G
Am J Perinatol; 2010 May; 27(5):399-404. PubMed ID: 20013578
[TBL] [Abstract][Full Text] [Related]
14. Closure of patent ductus arteriosus with oral ibuprofen suspension in premature newborns: a pilot study.
Heyman E; Morag I; Batash D; Keidar R; Baram S; Berkovitch M
Pediatrics; 2003 Nov; 112(5):e354. PubMed ID: 14595076
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the Mortality and In-Hospital Outcomes of Preterm Infants Treated with Ibuprofen for Patent Ductus Arteriosus with or without Clinical Symptoms Attributable to the Patent Ductus Arteriosus at the Time of Ibuprofen Treatment.
Yoo H; Lee JA; Oh S; Jung YH; Sohn JA; Shin SH; Choi CW; Kim EK; Kim HS; Kim BI
J Korean Med Sci; 2017 Jan; 32(1):115-123. PubMed ID: 27914140
[TBL] [Abstract][Full Text] [Related]
16. Necrotizing enterocolitis and gastrointestinal complications after indomethacin therapy and surgical ligation in premature infants with patent ductus arteriosus.
O'Donovan DJ; Baetiong A; Adams K; Chen A; Smith EO; Adams JM; Weisman LE
J Perinatol; 2003 Jun; 23(4):286-90. PubMed ID: 12774134
[TBL] [Abstract][Full Text] [Related]
17. Comparison of oral ibuprofen and indomethacin therapy for patent ductus arteriosus in preterm infants.
Fakhraee SH; Badiee Z; Mojtahedzadeh S; Kazemian M; Kelishadi R
Zhongguo Dang Dai Er Ke Za Zhi; 2007 Oct; 9(5):399-403. PubMed ID: 17937843
[TBL] [Abstract][Full Text] [Related]
18. What happens when the patent ductus arteriosus is treated less aggressively in very low birth weight infants?
Kaempf JW; Wu YX; Kaempf AJ; Kaempf AM; Wang L; Grunkemeier G
J Perinatol; 2012 May; 32(5):344-8. PubMed ID: 21818064
[TBL] [Abstract][Full Text] [Related]
19. Indomethacin tocolysis increases postnatal patent ductus arteriosus severity.
Hammerman C; Glaser J; Kaplan M; Schimmel MS; Ferber B; Eidelman AI
Pediatrics; 1998 Nov; 102(5):E56. PubMed ID: 9794986
[TBL] [Abstract][Full Text] [Related]
20. [Ibuprofen--a new application for pharmacological closure of patent ductus arteriosus in preterm infants. Preliminary report].
Adamska E
Med Wieku Rozwoj; 2000; 4(2 Suppl 3):65-71. PubMed ID: 11328971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]